CClinicalTrials.gg
CompletedNCT00806130Updated Dec 29, 2023

Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients

An observational study in Chronic Kidney Failure and Renal Dialysis, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years to 105 Years. Per ClinicalTrials.gov, last updated 2023-12-29.

Sponsored by Norwegian University of Science and Technology · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
40
Ages
18 Years to 105 Years
Sex
All
01

Study summary

The purpose of this study is to assess health related quality of life and its predictors among chronic dialysis patients and to assess cognitive function using 3 different tests.

(undergraduate medical student research project; not published)

02

Conditions studied

  • Chronic Kidney Failure
  • Renal Dialysis
03

In context

Renal Insufficiency

1,995 studies on the registry are indexed under Renal Insufficiency; 173 are open to participants now.

This study's enrollment of 40 is below the median of 149 across 394 observational studies indexed under Renal Insufficiency.

Browse Renal Insufficiency studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 105 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with end-stage renal disease and in active dialysis treatment in the Norwegian county of Sør-Trøndelag.

Inclusion criteria

  • Chronic kidney failure
  • Active dialysis treatment
  • Aged over 18 years
  • Able to read and answer the quality of life questionaire

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
40 participants (actual)
06

Study locations

1 site
  • Trondheim, Sør-Trøndelag, Norway
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00806130
Lead sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital
Responsible party
Sponsor
First posted
Dec 10, 2008
Start date
Sep 2008
Primary completion
Nov 2008
Completion
Nov 2008
Last update
Dec 29, 2023

Study contacts

Inger Karin Lægreid, MD
principal investigator · Norwegian University of Science and Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion